$INOH announces that it intends to commence its early detection testing for lung cancer using the sputum cytology technology licensed from its Vice-President of Technology, Mel Ehrlich, Ph.D.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.